Evidence map›Paper›PMID 38823688›Full record

ArticleVirus research2024

Sarbecovirus disease susceptibility is conserved across viral and host models.

Sarah R Leist, Alexandra Schäfer, Ellen L Risemberg, Timothy A Bell, Pablo Hock, Mark R Zweigart, Colton L Linnertz, Darla R Miller, Ginger D Shaw, Fernando Pardo Manuel de Villena and 3 more

Abstract read
In one paragraph

Article in Virus research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Animal models of Long Covid: A hit-and-run disease.Science translational medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sarah R LeistDepartment of Epidemiology, University of North Carolina at Chapel Hill, United States.
Alexandra SchäferDepartment of Epidemiology, University of North Carolina at Chapel Hill, United States.
Ellen L RisembergCurriculum in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, United States; Department of Genetics, University of North Carolina at Chapel Hill, United States.
Timothy A BellDepartment of Genetics, University of North Carolina at Chapel Hill, United States.
Pablo HockDepartment of Genetics, University of North Carolina at Chapel Hill, United States.
Mark R ZweigartDepartment of Epidemiology, University of North Carolina at Chapel Hill, United States.
Colton L LinnertzDepartment of Genetics, University of North Carolina at Chapel Hill, United States.
Darla R MillerDepartment of Genetics, University of North Carolina at Chapel Hill, United States.
Ginger D ShawDepartment of Genetics, University of North Carolina at Chapel Hill, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States.
Fernando Pardo Manuel de VillenaDepartment of Genetics, University of North Carolina at Chapel Hill, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States.
Martin T FerrisDepartment of Genetics, University of North Carolina at Chapel Hill, United States. Electronic address: mtferris@email.unc.edu.
William ValdarDepartment of Genetics, University of North Carolina at Chapel Hill, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States. Electronic address: william.valdar@unc.edu.
Ralph S BaricDepartment of Epidemiology, University of North Carolina at Chapel Hill, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, United States; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, United States. Electronic address: rbaric@email.unc.edu.

Funding

Unlocking Zika Virus Immune Control and Pathogenesis with the Collaborative CrossU19AI100625 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PARDO-MANUEL DE VILLENA, FERNANDO · 2012 to 2021
$36.6M
Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI Neil King, David Veesler · 2022 to 2026
$15.3M
Mechanisms of MERS-CoV Entry, Cross-species Transmission and PathogenesisR01AI110700 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, LI, FANG · 2015 to 2024
$7.4M
Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast AsiaU01AI151797 · NIAID · ECOHEALTH ALLIANCE, INC. · PI DASZAK, PETER · 2020 to 2023
$6.0M
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2R01AI157155 · NIAID · WASHINGTON UNIVERSITY · PI BARIC, RALPH S, CROWE, JAMES E · 2020 to 2024
$6.0M
Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative CrossR01AI157253 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, HEISE, MARK T · 2020 to 2024
$3.8M
Statistical Modeling of Multiparental and Genetic Reference PopulationsR35GM127000 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI William Valdar · 2018 to 2026
$3.1M
Predoctoral Training Program in Bioinformatics and Computational BiologyT32GM135123 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael Isaiah Love, William Valdar · 2021 to 2026
$1.7M
NIAID NIH HHS P01 AI167966NIAID NIH HHS R01 AI110700NIAID NIH HHS R01 AI157155NIAID NIH HHS R01 AI157253NIAID NIH HHS U01 AI151797NIAID NIH HHS U19 AI100625NIGMS NIH HHS R35 GM127000NIGMS NIH HHS T32 GM135123
6 · The paper itself

Abstract

Coronaviruses have caused three severe epidemics since the start of the 21

Indexed as

COVID-19Disease Models, AnimalQuantitative Trait LociSARS-CoV-2AnimalsChromosome MappingCollaborative Cross MiceDisease SusceptibilityFemaleGenetic Predisposition to DiseaseHumansMaleMiceSevere acute respiratory syndrome-related coronavirusCollaborative CrossCoronavirusCOVID-19GeneticsMouse modelsQTLSARSSARS-CoVSARS-CoV-2

Identifiers

PMID38823688
PMCPMC11225686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.